Clinical Trial Update: ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer. [Phase 1, Phase 2]

View source ↗

Summary

The document summarizes a Phase 1/Phase 2 clinical trial evaluating ASKB589 in combination with CAPOX chemotherapy and PD-1 inhibitors for patients with advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• ASKB589
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• PD-1 inhibitor

Snippet

Sponsor: AskGene Pharma, Inc. | Conditions: Gastric Cancer, Gastroesophageal Cancer (GC) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING